Replies to post #621189 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Do not think any company could remain this stupid with regard to communication.

Never underestimate Linda Powers and NWBO when it comes to not communicating. What we think are rational benchmarks do not work for them as observing them teaches that silence is a strategy in search of a justification.

Waiting on TLD and not messing up the trial was previously touted as the reason and then the JA was added and when nothing changed with the JA now it’s approval and then when we have sn approval it might be approval in every jurisdiction including South Sudan.

It is hard to believe that we would not get past a dollar post approval in say the UK but if I had predicted this situation back in September 2020 after they announced TLD was coming that very month I’d have been told I was spreading unwarranted fear. Not that I predicted it then because even I got taken in a bit by false hope.

As always we’ll see, though maybe not until 2023 is another wasted year and sadly another last year for many people (mostly patients but some shareholders) this leadership team is forcing to wait with time they don’t have.